WED.T: 0.25  +0.00
20 Min Delay
Request Feedback

Press Release

DateSubject
May 12, 2008 Westaim announces 2008 first quarter results
May 6, 2008 Webcast Advisory - The Westaim Corporation Webcast of Annual Meeting of Shareholders
February 15, 2008 Westaim announces 2007 year-end results
February 11, 2008 Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Fourth Quarter Results
November 26, 2007 Westaim reduces ABCP exposure
November 13, 2007 Westaim announces 2007 third quarter results
November 7, 2007 Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Third Quarter Results
November 2, 2007 The Westaim Corporation update on status of short-term investments
October 9, 2007 Westaim receives delisting notice from NASDAQ
August 20, 2007 The Westaim Corporation statement on status of short-term investments
August 9, 2007 Westaim announces 2007 second quarter results
August 2, 2007 The Westaim Corporation - Webcast Advisory
May 23, 2007 The Westaim Corporation announces operational and organizational changes
May 8, 2007 The Westaim Corporation sells Fort Saskatchewan real estate holdings for $13.5M
May 1, 2007 Westaim announces 2007 first quarter results
April 25, 2007 The Westaim Corporation - Webcast advisory
April 23, 2007 The Westaim Corporation to undertake review of business strategy
April 13, 2007 The Westaim Corporation announces receipt of NASDAQ Staff Deficiency Letter
February 15, 2007 Westaim announces 2006 year-end results
February 8, 2007 Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2006 Fourth Quarter Results
November 7, 2006 Westaim announces 2006 third quarter results
November 2, 2006 Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2006 Third Quarter Results
September 25, 2006 iFire's TDEL technology recognized as a key flat panel display technology by Chinese government
September 21, 2006 NUCRYST Pharmaceuticals announces preliminary results of Phase 2 Dermatology Study
August 9, 2006 Westaim announces 2006 second quarter results
August 2, 2006 Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2006 Second Quarter Results
May 3, 2006 Westaim announces 2006 first quarter results
May 2, 2006 The Westaim Corporation Annual General Meeting of Shareholders
April 26, 2006 Webcast Advisory - The Westaim Corporation Webcast of Annual Meeting of Shareholders and Investor Briefing
April 6, 2006 The Westaim Corporation Annual General Meeting of Shareholders
April 3, 2006 Webcast Advisory - The Westaim Corporation investor briefing and iFire Technology Corp. update
March 27, 2006 Webcast Advisory - The Westaim Corporation investor briefing and iFire Technology Corp. update
February 15, 2006 Westaim announces 2005 year-end results
February 14, 2006 Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2005 Fourth Quarter and Year-End Results
January 3, 2006 Westaim: iFire Technology’s pilot plant operational
December 22, 2005 The Westaim Corporation announces pricing for the Initial Public Offering of its NUCRYST Pharmaceuticals Corp. subsidiary
December 2, 2005 The Westaim Corporation announces filing of Registration Statement and Preliminary Prospectus for Proposed Initial Public Offering of its NUCRYST Pharmaceuticals Corp. subsidiary
November 2, 2005 Westaim announces plan to pursue IPO for NUCRYST Pharmaceuticals
November 2, 2005 Westaim announces 2005 third quarter results
August 4, 2005 Westaim announces 2005 second quarter results
May 4, 2005 Westaim announces 2005 first quarter results
April 1, 2005 The Westaim Corporation Annual General Meeting of Shareholders
February 17, 2005 Westaim announces 2004 year-end results
January 6, 2005 The Westaim Corporation appoints Nicolas W. Khoury as President of iFire Technology
November 3, 2004 Westaim announces 2004 third quarter results
October 6, 2004 The Westaim Corporation appoints Dr. Roger G.H. Downer to the Board of Directors
September 7, 2004 Westaim’s NUCRYST Pharmaceuticals reports Phase 2a clinical trial results of investigational drug in atopic dermatitis
August 9, 2004 Westaim announces 2004 second quarter results
August 4, 2004 The Westaim Corporation announces closing of equity financing
July 14, 2004 Westaim to raise $34 million through bought deal to fund iFire pilot production
May 5, 2004 Westaim announces 2004 first quarter results
February 19, 2004 Westaim announces 2003 year-end results
January 30, 2004 Westaim sells Ambeon division for $35 million
December 16, 2003 Westaim’s iFire Technology produces 34-inch color inorganic EL display
December 4, 2003 NUCRYST Pharmaceuticals begins first Phase 2 clinical trial of novel dermatology drug
November 4, 2003 Westaim announces 2003 third quarter results
August 6, 2003 Westaim announces 2003 second quarter results
July 22, 2003 Westaim appoints two new directors
May 20, 2003 Westaim’s iFire Technology demonstrates high-luminance Color-by-Blue™
April 30, 2003 Westaim announces 2003 first quarter results
April 29, 2003 Westaim’s iFire Technology increases manufacturing cost advantage
April 25, 2003 Westaim’s NUCRYST Pharmaceuticals to pursue new eczema drug
March 12, 2003 NUCRYST Pharmaceuticals announces additional European approvals
February 20, 2003 Westaim announces 2002 year-end results
January 20, 2003 Westaim announces initiatives to maximize shareholder value
January 15, 2003 Westaim appoints Barry M. Heck President & CEO
November 7, 2002 Westaim Announces 2002 Third Quarter Results
July 25, 2002 Westaim Announces 2002 Second Quarter Results
July 8, 2002 Westaim’s iFire Technology and Sanyo Electric Co., Ltd. of Japan collaborate on development of flat panel television technology
June 17, 2002 Westaim announces share buy back regulatory approval
June 13, 2002 Westaim Announces a Normal Course Issuer Bid
June 6, 2002 Westaim’s iFire Technology appoints flat panel display manufacturing expert
May 29, 2002 Westaim to increase focus on NUCRYST and iFire
April 26, 2002 Westaim Announces 2002 First Quarter Results
April 22, 2002 Westaim’s NUCRYST Pharmaceuticals appoints Paul J. Schechter to lead drug development and regulatory approval processes
February 21, 2002 Westaim announces 2001 year-end results
December 13, 2001 Westaim announces non-cash write-down
November 1, 2001 Westaim’s NUCRYST to pursue pharmaceutical applications for its proven nanotechnology
October 2, 2001 iFire Technology update on TDK Corporation partnership
July 31, 2001 Westaim Announces 2001 Second Quarter Results
June 5, 2001 iFire Technology first to demonstrate CRT-quality color
May 9, 2001 Smith & Nephew acquires burn business and exclusive license to new wound care technology from Westaim Biomedical
May 9, 2001 Westaim Announces 2001 First Quarter Results
April 24, 2001 Westaim updates shareholders at Annual General Meeting
April 19, 2001 Government of Canada invests $30 million in iFire Technology’s flat panel TV technology
March 22, 2001 Westaim’s iFire Technology hires Matsushita Electric Industrial Co., Ltd. flat panel display veteran
March 13, 2001 Westaim technology investment, Savvion, Licenses BusinessManager to Cisco Systems
February 21, 2001 Westaim Biomedical receives FDA Over-the-Counter clearance for Acticoat® products
February 13, 2001 Westaim announces 2000 year-end results
January 18, 2001 Westaim’s iFire Technology reaches commercial quality color milestone and validates new column drivers
January 2, 2001 Westaim sells Chemicals Division to Marsulex for $18 million
December 12, 2000 Westaim technology investment, Savvion, launches BusinessManager™3.0
December 6, 2000 Westaim technology investment, Savvion, works with BEA Systems for rapid deployment of scalable e-business services for mobile workers
November 27, 2000 Westaim technology investment, Savvion, joins forces with BV Solutions Group to deploy e-business process management solutions
November 1, 2000 Westaim's Surface Engineered Products’ CoatAlloy™-1100 coatings in high demand by global ethylene industry
October 26, 2000 Westaim Biomedical announces Japanese distributor for Acticoat® antimicrobial burn dressings
October 26, 2000 Westaim announces 2000 third-quarter results
October 17, 2000 Westaim Biomedical receives FDA clearance for 7-day chronic wound dressing
October 6, 2000 Westaim technology investment, Savvion, Opens European Headquarters to Drive Market Acceptance of Savvion BusinessManager™
October 2, 2000 Westaim technology investment, Savvion, demonstrates new business process management capabilities at Oracle OpenWorld 2000
September 6, 2000 Westaim technology investment, Savvion, partners with Mercator to extend application integration capabilities of business process management solution
August 30, 2000 Westaim technology investment, Savvion, enhances e-business management solution with support for HP-UX and AIX
August 22, 2000 Westaim technology investment, Savvion, signs agreement to integrate its BusinessManager into i2 Technologies’ leading eSolution Collaboration Suite
August 11, 2000 Westaim technology investment, Savvion, partners with Fujitsu
July 27, 2000 Westaim technology investment, Savvion, begins formal operations in Japan
July 27, 2000 Westaim announces 2000 second quarter results
July 6, 2000 Westaim's Surface Engineered Products launches Asian office at anti-coking symposium in Beijing
June 15, 2000 Westaim technology investment, Savvion, debuts mobile e-business
June 14, 2000 Westaim's Surface Engineered Products Launches European Operations
June 14, 2000 Westaim technology investment, Savvion, partners with Active Software to speed deployment of managed eBusiness solutions
June 14, 2000 Westaim technology investment, Savvion, raises the standard in e-Business management with release of BusinessManager™ 2.0
June 9, 2000 Savvion Initiates New Global Corporate Strategy to Establish Leadership Position in Business Management Arena
May 16, 2000 Westaim’s iFire Technology demonstrates iFire™-based TV prototype display
April 27, 2000 Westaim technology investment, TDI, completes US$25 million first-round financing
April 27, 2000 Westaim announces 2000 first quarter results
April 18, 2000 Westaim’s iFire Technology Inc. demonstrates 17-inch full-color prototype video display
April 18, 2000 The Westaim Corporation announces Nasdaq listing
April 13, 2000 Westaim Biomedical receives FDA approval for new chronic wound dressings
February 29, 2000 Westaim’s Surface Engineered Products introduces CoatAlloy™-1100 anti-coking coating with breakthrough high-temperature performance
February 23, 2000 Westaim takes stake in e-business software leader, Technology Deployment International, Inc (TDI)
February 17, 2000 Westaim’s iFire Technology Inc. and TDK Corporation of Japan announce equity partnership for production of newly developed flat panel display
February 17, 2000 Westaim announces 1999 year-end results
February 1, 2000 Westaim’s iFire Technology Inc. demonstrates flat panel prototype with product-quality brightness
January 27, 2000 Westaim’s Surface Engineered Products announces largest order to date
December 9, 1999 Westaim announces multi-million dollar contract with China’s Nanjing Mint
December 6, 1999 Westaim Biomedical names wound care executive as new president
October 27, 1999 Westaim announces 1999 third-quarter results
September 21, 1999 Westaim Biomedical's Acticoat® Dressing Demonstrates Superior Fungicidal Capability
September 17, 1999 Surface Engineered Products is a finalist for the 1999 Alberta Science and Technology Leadership Awards
August 19, 1999 Westaim’s Surface Engineered Products announces order from largest North American ethylene producer
July 21, 1999 Westaim Announces Second Quarter Results
May 27, 1999 Westaim's Surface Engineere